UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000026050
Receipt No. R000029938
Scientific Title Phase II study to assess efficacy, safety & immunological biomarker of anti PD-L1 antibody + anti CTLA-4 antibody in combination with hormone therapy in patients with hormone receptor positive HER2-negative recurrent or metastatic breast cancer
Date of disclosure of the study information 2017/02/08
Last modified on 2019/02/07 06:04:51

No. Disposal Last modified on Item of update
1 Insert 2017/02/08 13:57:47
2 Update 2018/03/02 19:26:54 Anticipated trial start date
3 Update 2018/04/09 16:04:41 Division name
Division name
TEL
Organization
Organization
Division name
Division name
Address
TEL
Institute
4 Update 2018/08/25 14:16:14 Recruitment status
5 Update 2018/10/31 06:24:08 Email
Organization
Organization
Address
Email
6 Update 2019/02/07 06:04:51 Email
Email


Contact us.